Industry Analysis: Dynamic Extractions Limited

1. Industry Classification

Sector: Research and Experimental Development on Natural Sciences and Engineering (SIC 72190)

Key Characteristics: This classification places Dynamic Extractions within the UK's scientific R&D sector—a space characterised by long development cycles, high capital requirements prior to commercialisation, and significant intellectual property creation. Companies operating under SIC 72190 typically engage in applied research, prototype development, and technology licensing rather than volume manufacturing. The sector spans sub-sectors including environmental technology, process engineering, and specialist separation science—the latter being consistent with the company's nomenclature suggesting extraction technology development.

The UK R&D services sector comprises approximately 35,000 enterprises, with the majority being micro or small entities. Successful operators in this space typically demonstrate: protected intellectual property portfolios, clear pathways to commercialisation through licensing or product sales, and sufficient capitalisation to sustain operations through extended development phases.

2. Relative Performance

Against Industry Benchmarks: Dynamic Extractions' financial metrics fall dramatically below sector norms across virtually every dimension:

The company is technically insolvent with net liabilities exceeding assets by over £824,000. Current liabilities of £885,576 dwarf current assets of just £28,418, yielding a current ratio of 0.03x—far below the 1.0x minimum considered viable. The accumulated P&L deficit of £2.24 million indicates sustained operating losses over many years, having consumed the entire £1.41 million share premium and called-up share capital.

Trajectory Analysis: The financial deterioration has been progressive and severe. As recently as FY2017, the company reported net assets of £508,293 and shareholders' funds of £1.41 million. By FY2018, net assets turned negative (£133,099 net assets but shareholders' funds dropped to £1.41M minus accumulated losses), and the position has worsened every subsequent year. This represents a seven-year continuous decline—far exceeding typical R&D venture timelines for achieving commercialisation.

3. Sector Trends Impact

UK R&D Funding Environment: The company has operated through a period of significant policy shifts affecting the R&D sector:

• R&D Tax Credit Regime Changes: The 2023 reduction in payable R&D tax credit rates for SMEs (from 14.5% to 10%) and the merger of schemes from April 2024 have reduced cash support available to loss-making R&D companies precisely like Dynamic Extractions. This policy change directly impacts working capital for pre-revenue ventures.

• Post-Brexit Research Funding: Loss of automatic access to Horizon Europe funding until reassociation in 2024 created a gap for collaborative R&D projects. Smaller specialist operators without university partnerships were disproportionately affected.

• Venture Capital Selectivity: The UK deep-tech VC market has become more disciplined, with investors demanding clearer commercialisation milestones. Oxford Technology 2 VCT's continued 25-50% stake suggests historical investment, but the absence of fresh capital injection indicates limited investor appetite for further funding rounds.

• Welsh R&D Ecosystem: Operating from Mamhilad Park Estate in Torfaen places the company within Wales's smaller R&D ecosystem, which receives proportionally less private investment than the Golden Triangle (London-Oxford-Cambridge) corridor.

Sector-Specific Dynamics: The separation and extraction technology market has seen increased interest in environmental applications (water treatment, mineral recovery, circular economy processes). However, commercialisation typically requires demonstration-scale facilities and regulatory approvals—capital-intensive stages that Dynamic Extractions appears unable to fund.

4. Competitive Positioning

Position Assessment: Distressed/Failing Venture

Dynamic Extractions occupies a distressed niche position rather than any competitive standing within the R&D sector. The evidence points to a company that has failed to transition from development to commercialisation:

Weaknesses vs. Typical Competitors:

• Capital Structure: The £3.43 million share capital figure in the overview appears to be a data anomaly; the filed accounts show called-up share capital of only £3,348. The £1.41 million share premium represents exhausted investor capital with no returns generated.

• Operational Scale: With only 2 employees, the company lacks critical mass for meaningful R&D activity. Comparable active R&D SMEs in separation technology typically maintain teams of 8-15 specialists.

• Asset Base: Tangible assets of £6,717 (nearly fully depreciated plant and machinery) and intangible assets of £28,861 (patents amortising at 5% annually) represent a minimal operational footprint. The intangible assets likely relate to patent portfolios—the company's primary remaining value proposition.

• Revenue Generation: The dramatic decline in debtors from £94,238 (FY2024) to £16,862 (FY2025) suggests minimal trading activity. For context, active R&D SMEs in this sector typically report turnover of £250k-£2M.

• Going Concern Dependency: The explicit reliance on Protem Services Limited (the >75% controlling shareholder) for working capital support represents a critical vulnerability. This related-party dependency is unusual for competitive ventures and suggests the company cannot sustain itself through operations.

Strengths (Limited): - Patent portfolio (intangible assets) may retain licensing potential - VCT backing provides some institutional credibility - Two-decade operating history indicates some enduring capability

Ownership and Control Context: Protem Services Limited's dominant position (>75% shares, voting rights, and director appointment power) means strategic decisions rest with a single entity. Oxford Technology 2 VCT's minority stake represents patient capital that has not forced exit or liquidation—common for VCTs holding underwater positions where crystallising losses offers no tax advantage.

Sector Comparison: Typical R&D Venture Lifecycle

Active and successful R&D SMEs in natural sciences/engineering typically demonstrate: - Years 1-3: Investment phase with negative cash flows, funded by equity - Years 3-5: Prototype development and initial licensing revenue - Years 5-7: Commercialisation and path to profitability - Years 7+: Sustainable operations or acquisition exit

Dynamic Extractions, incorporated in 2001, is in its 24th year—far beyond typical development timelines. The transition from positive net assets (FY2017) to insolvency occurred during what should have been the commercialisation phase, suggesting fundamental challenges in market adoption or technology viability.